Sun Pharmaceutical Industries slipped 4.30% to 1,778.85 after the US District Court of New Jersey has decided to grant a preliminary injunction delaying the launch of Leqselvi (Baldness treatment) in the US.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
